SHANGHAI JUNSHI BIO YC1 (8SJ) — Financial Flexibility Index
SHANGHAI JUNSHI BIO YC1 (8SJ) has a Financial Flexibility Index of 0.04x as of December 2025. Free cash flow of €253.78 Million (operating CF €-514.51 Million minus capex €768.30 Million) represents 0% of total liabilities (€6.33 Billion). Check SHANGHAI JUNSHI BIO YC1 liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SHANGHAI JUNSHI BIO YC1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SHANGHAI JUNSHI BIO YC1 across 5 annual periods. See working capital to net assets of SHANGHAI JUNSHI BIO YC1 to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SHANGHAI JUNSHI BIO YC1 (2021–2025)
Year-by-year free cash flow to debt coverage for SHANGHAI JUNSHI BIO YC1. For the full company profile including market capitalisation, see 8SJ company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €253.78 Million | €-514.51 Million | €6.33 Billion | ▲ +125.9% |
| 2024 | -0.16x | €-751.85 Million | €-1.44 Billion | €4.85 Billion | ▲ +47.3% |
| 2023 | -0.29x | €-1.18 Billion | €-2.01 Billion | €4.02 Billion | ▲ +40.8% |
| 2022 | -0.50x | €-1.38 Billion | €-1.78 Billion | €2.78 Billion | ▼ -652.5% |
| 2021 | 0.09x | €244.33 Million | €-641.90 Million | €2.72 Billion | — |